文献速递肝病炎症性肠病

肠道致病共生菌来源外膜囊泡驱动原发性硬化性胆管炎相关炎症性肠病的肝脏炎症与纤维化

Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
PubMed 文献 · Gastroenterology · 2024-07-09

本研究结合临床前小鼠模型、胆管类器官及患者队列(PSC 22例、PSC-IBD 45例、对照27例),发现肠道致病共生菌释放的外膜囊泡(OMVs)易位至肝脏,与NLRP3炎症小体积累相关,并通过Toll样受体4和NLRP3-gasdermin-D信号通路促进肝脏炎症与纤维化。在PSC-IBD患者全身循环和严重纤维化肝区证实OMVs存在,提示OMVs可能是参与PSC-IBD发病的关键新环境因子及纤维化治疗潜在靶点。

要点

  • PSC-IBD中肠道致病共生菌来源OMVs易位至肝脏,与细菌感知增强及NLRP3炎症小体积累相关。
  • OMVs的促炎和促纤维化特性依赖于Toll样受体4和NLRP3-gasdermin-D信号通路。
  • 给予Mdr2-/-小鼠肠道致病共生菌来源OMVs可显著增强肝脏炎症和纤维化。

核心结论

  • 本研究证明肠道致病共生菌释放的OMVs穿越黏膜屏障,促进PSC-IBD的肝脏炎症和纤维化。
  • OMVs可能是与其他疾病因素相互作用引起炎症的关键新环境因子,并定义纤维化治疗的潜在新靶点。

研究设计与样本

  • 采用临床前小鼠模型及胆管类器官获取机制数据。
  • 概念验证研究纳入PSC患者22例、PSC-IBD患者45例和对照个体27例,检测血清和肝活检中的OMVs。

主要发现

  • 在临床前模型系统和PSC-IBD患者中,OMVs易位至肝脏与细菌感知增强及NLRP3炎症小体积累相关。
  • 利用胆管类器官将OMVs的促炎和促纤维化特性归因于依赖Toll样受体4和NLRP3-gasdermin-D的信号通路。
  • OMVs的免疫刺激潜力在巨噬细胞和肝星状细胞中得到证实。
  • 给予Mdr2-/-小鼠肠道致病共生菌来源OMVs后,观察到肝脏炎症和纤维化显著增强。
  • 在PSC-IBD患者队列中证实OMVs存在于全身循环和严重纤维化肝区。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC), often associated with inflammatory bowel disease (IBD), presents a multifactorial etiology involving genetic, immunologic, and environmental factors. Gut dysbiosis and bacterial translocation have been implicated in PSC-IBD, yet the precise mechanisms underlying their pathogenesis remain elusive. Here, we describe the role of gut pathobionts in promoting liver inflammation and fibrosis due to the release of bacterial outer membrane vesicles (OMVs). METHODS: Preclinical mouse models in addition to ductal organoids were used to acquire mechanistic data. A proof-of-concept study including serum and liver biopsies of a patient cohort of PSC (n = 22), PSC-IBD (n = 45), and control individuals (n = 27) was performed to detect OMVs in the systemic circulation and liver. RESULTS: In both preclinical model systems and in patients with PSC-IBD, the translocation of OMVs to the liver correlated with enhanced bacterial sensing and accumulation of the NLRP3 inflammasome. Using ductal organoids, we were able to precisely attribute the pro-inflammatory and pro-fibrogenic properties of OMVs to signaling pathways dependent on Toll-like receptor 4 and NLRP3-gasdermin-D. The immunostimulatory potential of OMVs could be confirmed in macrophages and hepatic stellate cells. Furthermore, when we administered gut pathobiont-derived OMVs to Mdr2-/- mice, we observed a significant enhancement in liver inflammation and fibrosis. In a translational approach, we substantiated the presence of OMVs in the systemic circulation and hepatic regions of severe fibrosis using a PSC-IBD patient cohort. CONCLUSIONS: This study demonstrates the contribution of gut pathobionts in releasing OMVs that traverse the mucosal barrier and, thus, promote liver inflammation and fibrosis in PSC-IBD. OMVs might represent a critical new environmental factor that interacts with other disease factors to cause inflammation and thus define potential new targets for fibrosis therapy.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Dorner H, Stolzer I, Mattner J, et al. Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease. Gastroenterology. 2024. PMID: 38992449. doi:10.1053/j.gastro.2024.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。